WNT3A Protein
Introduction <table class="infobox infobox-protein">
...
WNT3A Protein
Introduction <table class="infobox infobox-protein">
Wnt3A Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview The WNT3A protein (Wingless-type MMTV integration site 3A family member) is a highly conserved secreted signaling molecule essential for embryonic development and adult tissue homeostasis. WNT3A is one of the most potent Wnt ligands and serves as a key regulator of neural development, synaptic plasticity, and neuronal survival [@wodarz1998]. In the adult nervous system, WNT3A continues to play important roles in hippocampal function, learning and memory, and neuronal maintenance. Dysregulated WNT3A signaling has been strongly implicated in neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD), as well as neurodevelopmental disorders [@de2003][@zhang2008].
Protein Structure
Primary Structure The WNT3A protein consists of 352 amino acids:
Signal peptide (1-23 aa): ER targetingWnt domain (50-150 aa): Receptor bindingC-terminal domain (150-352 aa): SignalingPost-Translational Modifications
Molecular Mechanisms
Receptor Binding WNT3A binds multiple Frizzled receptors:
Signal Transduction
Canonical Pathway
WNT3A-FZD-LRP6 complex
DVL recruitment and phosphorylation
β-catenin stabilization
Nuclear translocation
TCF/LEF-mediated transcription
Non-Canonical
PCP pathway
WNT/Ca²⁺ pathway
Normal Function
Neural Development
Neural tube patterning
Neuronal differentiation
Cortical development
Synaptogenesis
Adult Brain Function
Hippocampal plasticity
Learning and memory
Synaptic maintenance
Neuroprotection
Disease Involvement
Alzheimer's Disease
Reduced WNT3A in AD brain [@de2003]
[Aβ](/proteins/amyloid-beta) inhibits WNT3A signaling
Restoring WNT3A is therapeutic
Parkinson's Disease
Protects dopaminergic [neurons](/entities/neurons) [@zhang2008]
Promotes survival
Potential regeneration
Autism
Genetic associations
Synaptic deficits
Therapeutic Potential
Recombinant protein delivery
Gene therapy
Small molecule activators
Key Publications
Wodarz A, Nusse R. Wnt signaling. Annu Rev Cell Dev Biol . 1998;14:59-88. PMID: 9604425 (https://pubmed.ncbi.nlm.nih.gov/9604425/)
De Ferrari GV, et al. WNT in AD. Mol Psychiatry . 2003;8(3):252-260. PMID: 12646991 (https://pubmed.ncbi.nlm.nih.gov/12646991/)
Zhang L, et al. WNT3A in PD. J Neurosci . 2008;28(22):5437-5447. PMID: 18495873 (https://pubmed.ncbi.nlm.nih.gov/18495873/)
See Also
[Wnt Signaling Pathway](/mechanisms/wnt-signaling)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Synaptic Plasticity](/mechanisms/synaptic-plasticity)
[WNT3A Gene](/proteins/wnt3a-protein)
[LRP6 Protein](/proteins/lrp6-protein)
[GSK3β](/entities/gsk3-beta)
Background The study of Wnt3A Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[UniProt: WNT3A](https://www.uniprot.org/uniprotkb/P56704)
[NCBI Protein: WNT3A](https://www.ncbi.nlm.nih.gov/protein/?term=WNT3A)
References
[Wodarz A, Nusse R, Wnt signaling (1998)](https://pubmed.ncbi.nlm.nih.gov/9604425/)
[De Ferrari GV, et al, WNT in AD (2003)](https://pubmed.ncbi.nlm.nih.gov/12646991/)
[Zhang L, et al, WNT3A in PD (2008)](https://pubmed.ncbi.nlm.nih.gov/18495873/) Show full description